Of the $12.9 billion, $5.7 billion was spent on treatment in ambulatory settings and $2.4 billion was spent on prescription drugs. AHRQ also found private insurance paid 68 percent of the cost while 15 percent was paid out of pocket. Medicaid and Medicare paid 10 percent and 3 percent respectively.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.